Smith Shellnut Wilson LLC Amgen Inc Transaction History

Smith Shellnut Wilson LLC

$218 Million
Q3 2024

A detailed history of Smith Shellnut Wilson LLC transactions in Amgen Inc stock. As of the latest transaction made, Smith Shellnut Wilson LLC holds 1,144 shares of AMGN stock, worth $366,263. This represents 0.17% of its overall portfolio holdings.

Number of Shares

1,144

Previous 1,144 -0.0%

Holding current value

$366,263

Previous $357,000 3.08%

% of portfolio

0.17%

Previous 0.18%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $4,285 - $5,067	-20 Reduced 1.72%	1,144 $253,000
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $9,228 - $10,269	-40 Reduced 3.32%	1,164 $283,000
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $4,823 - $5,336	-22 Reduced 1.79%	1,204 $291,000
Q4 2021 Feb 03, 2022	BUY	$198.88 - $227.6 $4,972 - $5,690	25 Added 2.08%	1,226 $276,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $8,915 - $10,445	-42 Reduced 3.38%	1,201 $255,000
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $30,598 - $33,947	131 Added 11.78%	1,243 $303,000
Q1 2021 Apr 06, 2021	SELL	$221.91 - $258.6 $22,412 - $26,118	-101 Reduced 8.33%	1,112 $277,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $30,739 - $34,184	-131 Reduced 9.75%	1,213 $308,000
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $26,242 - $34,804	-144 Reduced 9.68%	1,344 $272,000
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $16,192 - $19,401	-93 Reduced 5.88%	1,488 $288,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $29,481 - $33,232	163 Added 11.5%	1,581 $300,000
Q1 2018 Apr 24, 2018	SELL	$169.43 - $198.0 $179,087 - $209,286	-1,057 Reduced 42.71%	1,418 $242,000
Q3 2017 Nov 17, 2017	BUY	$167.29 - $191.0 $414,042 - $472,725	2,475	2,475 $461,000

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Shellnut Wilson LLC , based on Form 13F filings with the SEC.

News

Stay updated on Smith Shellnut Wilson LLC with notifications on news.

Account

Smith Shellnut Wilson LLC Amgen Inc Transaction History